|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.310 SEK | +1.76% |
|
-2.53% | +2.21% |
| 04-21 | Larkberget to carry out rights issue of units totaling SEK 14.9 mln | RE |
| 04-17 | Larkberget net asset value per share at SEK 3.04 | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 4.62M | - | - | - | - | - |
| 56.21B | |||||
| 55.38B | |||||
| 23.75B | - | ||||
| 23.19B | - | ||||
| 18.14B |
- Stock Market
- Stocks
- LARK Stock
- Charts CombiGene AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
